Page last updated: 2024-10-22

theophylline and Low Bone Density

theophylline has been researched along with Low Bone Density in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Theophylline treatment resulted in a time-dependent (at 4- and 8 weeks) bone loss."1.43Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats. ( Bhadauria, S; Chattopadhyay, N; China, SP; Gayen, JR; Godbole, MM; Gupta, SK; Hossain, Z; Khan, K; Mandalapu, D; Mittal, M; Pal, S; Porwal, K; Sanyal, S; Sharma, VL; Shrivastava, R; Taneja, I; Trivedi, AK; Wahajuddin, M, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pal, S1
Khan, K1
China, SP1
Mittal, M1
Porwal, K1
Shrivastava, R1
Taneja, I1
Hossain, Z1
Mandalapu, D1
Gayen, JR1
Wahajuddin, M1
Sharma, VL1
Trivedi, AK1
Sanyal, S1
Bhadauria, S1
Godbole, MM1
Gupta, SK1
Chattopadhyay, N1

Other Studies

1 other study available for theophylline and Low Bone Density

ArticleYear
Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.
    Toxicology and applied pharmacology, 2016, Mar-15, Volume: 295

    Topics: Animals; Apoptosis; Biomarkers; Bone Diseases, Metabolic; Bone Marrow; Bone Regeneration; Calcifedio

2016